This tribute was submitted by a reader as part of our Veterans Week initiative, brought to you by VFW Post 291, Agent of VFW Ohio Charities. If you’d like to […] ...
NEW YORK – Neurogene on Monday said after the market closed that it will stop advancing NGN-101 as a treatment for CLN5 Batten disease, a very rare genetic disorder. The New York-based company said it ...